Brainstorm Cell Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BCLI and buy or sell other stocks, ETFs, and their options commission-free!About BCLI
Brainstorm Cell Therapeutics, Inc. is a biotechnology company, which develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Alzheimer's disease, and other neurodegenerative diseases. Its pipeline, NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and improve neurological function.
CEOChaim Lebovits
CEOChaim Lebovits
Employees29
Employees29
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2000
Founded2000
Employees29
Employees29
BCLI Key Statistics
Market cap52.42M
Market cap52.42M
Price-Earnings ratio-15.25
Price-Earnings ratio-15.25
Dividend yield—
Dividend yield—
Average volume385.89K
Average volume385.89K
High today$0.67
High today$0.67
Low today$0.625
Low today$0.625
Open price$0.63
Open price$0.63
Volume17.57K
Volume17.57K
52 Week high$0.7927
52 Week high$0.7927
52 Week low$0.134
52 Week low$0.134
People also own
Based on the portfolios of people who own BCLI. This list is generated using Robinhood data, and it’s not a recommendation.